DFDA

Trichloroacetic Acid (TCA)

Treatment for Hpv Infection

Typical Dosage: 80-90% solution, applied weekly

Effectiveness
80%
Safety Score
80%
Clinical Trials
4
Participants
6K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
80
DangerousModerateSafe
Treatment Details
Dosage Range
80-90% solution, applied weekly
Time to Effect
1-4 weeks per session
Treatment Duration
Multiple sessions over 4-12 weeks
Evidence Quality
HIGH
Number Needed to Treat (NNT)
2(Treat 2 patients to see 1 additional successful outcome)
Confidence Score
88%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$1,000
Side Effect Mgmt:$50
Total Annual:$1,050
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOOD
QALYs Gained
Outcome-Based Costs
Cost per Responder
$1,312.5
Cost per Remission
$1,312.5
Comparison vs Cryotherapy
Cost Difference
$0/year
Same cost
QALY Difference
0.00 QALYs
Same outcomes
Dominance
No dominance
Trichloroacetic Acid (TCA) Outcomes

for Hpv Infection

Efficacy Outcomes
Overall Effectiveness
+80%
Response Rate
+80%
Remission Rate
+80%
Common Side Effects
Local pain
+80%
Burning sensation
+60%
Ulceration
+40%
Scarring
+7%

Sources:

nih.gov
fortunejournals.com
researchgate.net

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov

Completed Clinical Trials
3 completed trials for Trichloroacetic Acid (TCA) in Hpv Infection

Efficacy and Safety of TCA vs. ECA for the Treatment of AIN in HIV-positive Patients

NCT02615860COMPLETEDNA
View Study
560 participants
INTERVENTIONAL
Essen, Germany
Started: Nov 1, 2015

The Effect of Oral Nanocurcumin as an Adjuvant Therapy for Anogenital Warts: Evaluation of Clinical Improvement, NFĸB, IFN-γ, and FOXP3+TReg From Lesions Tissue

NCT06281353COMPLETEDPHASE2, PHASE3
View Study
78 participants
INTERVENTIONAL
Jakarta Pusat, Indonesia
Started: Aug 16, 2022

Typing of Human Papilloma Virus (HPV) From Female Genital Warts

NCT01192282COMPLETED
View Study
156 participants
OBSERVATIONAL
Cape Town, South Africa
Started: Apr 1, 2010